לקסיבה

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

FOSAMPRENAVIR AS FOSAMPRENAVIR CALCIUM 700 MG

Disponibil de la:

GLAXO SMITH KLINE (ISRAEL) LTD

Codul ATC:

J05AE07

Forma farmaceutică:

TABLETS

Calea de administrare:

PER OS

Produs de:

GLAXO WELLCOME SA, SPAIN

Grupul Terapeutică:

FOSAMPRENAVIR

Indicații terapeutice:

Lexiva is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV) infection in adults. The following points should be considered when initiating therapy with Lexiva/ritonavir in protease inhibitor - experienced patients: - The protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that Lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - Once - daily administration of Lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Data de autorizare:

2012-01-01